Literature DB >> 4069475

Adrenal scintigraphy with 75Se selenonorcholestenol: a review.

C J Sudell, G M Blake, A A Gossage, D R Cullen, D S Munro.   

Abstract

We have reviewed 58 patients on whom adrenal scintigraphy has been performed using 75Se selenonorcholestenol. For 15 patients whose adrenal function was biochemically normal, the upper limit of normal of the 7 day adrenal uptake test was 0.45%, considerably higher than the generally accepted value of 0.3%. There is evidence from this group of patients that stress and obesity might account for uptakes in the range 0.3-0.45%. The sensitivity of the uptake test is poor, with 7 out of 23 patients with Cushing's syndrome having uptakes within the normal range. Scintigraphy of such patients may still be useful in differentiating between unilateral and bilateral adrenal involvement.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4069475     DOI: 10.1097/00006231-198509000-00005

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  3 in total

1.  Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostate.

Authors:  G M Blake; M A Zivanovic; A J McEwan; D M Ackery
Journal:  Eur J Nucl Med       Date:  1986

2.  89Sr radionuclide therapy: dosimetry and haematological toxicity in two patients with metastasising prostatic carcinoma.

Authors:  G M Blake; M A Zivanovic; A J McEwan; V B Batty; D M Ackery
Journal:  Eur J Nucl Med       Date:  1987

3.  Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.

Authors:  E Reschini; A Catania
Journal:  Eur J Nucl Med       Date:  1991
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.